Literature DB >> 49653

A model for gastric cancer epidemiology.

P Correa, W Haenszel, C Cuello, S Tannenbaum, M Archer.   

Abstract

It is postulated that one major subtype of gastric carcinoma ("intestinal type") is the end- result of a series of mutations and cell transformation begun in the first decade of life. The mutagen could be a nitroso compound synthesised in the upper gastrointestinal tract by the action of nitrite (i.e., from food or saliva) on naturally occurring nitrogen compounds. Under normal conditions these nitroso compounds do not reach the gastric epithelial cell, presumably because their synthesis is inhibited by antioxidants present in food or because of their inability to pass the mucous barrier. The barrier may be overcome by abrasives or irritants such as hard grains, food with high sodium-chloride concentration, or surfactants. Once the first mutation occurs, the glandular gastric epithelium is gradually changed to intestinal-type epithelium, the mucous barrier altered, and the pH elevated. Under these conditions, bacteria proliferate in the gastric cavity and facilitate the conversion of nitrates to nitrites, thereby increasing the nitrite pool and the probability of formation of mutagenic-carcinogenic nitroso compounds. This process of gastric atrophy and intestinal metaplasia goes on for 30 to 50 years until some of the individuals affected have the final mutation or cell transformation which allows the cell to become autonomous and invade other tissues.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49653     DOI: 10.1016/s0140-6736(75)90498-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  269 in total

1.  Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.

Authors:  M F Dixon
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 2.  Carcinoma of the gastric stump: risks and pathogenesis.

Authors:  T C Northfield; C N Hall
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

3.  TFF1 inhibits proliferation and induces apoptosis of gastric cancer cells in vitro.

Authors:  Yanli Ge; Junjie Zhang; Jianchun Cao; Qiong Wu; Longe Sun; Likun Guo; Zhirong Wang
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

4.  Time trend and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre, Spain.

Authors:  N Aragonés; M Pollán; G López-Abente; M Ruiz; A Vergara; C Moreno; P Moreo; E Ardanaz
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

5.  Toward early detection of Helicobacter pylori-associated gastric cancer.

Authors:  Rachel Walker; Jan Poleszczuk; Jaime Mejia; Jae K Lee; Jose M Pimiento; Mokenge Malafa; Anna R Giuliano; Heiko Enderling; Domenico Coppola
Journal:  Gastric Cancer       Date:  2017-07-19       Impact factor: 7.370

6.  Influence of peroxisome proliferator-activated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Masakatsu Nakamura; Fangyu Wang; Naoko Maruyama; Yoshio Kamiya; Masahiko Nakamura; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

7.  Different gastric mucosa and CagA status of patients in India and Japan infected with Helicobacter pylori.

Authors:  Keiichi Fujiya; Naoyoshi Nagata; Tomohisa Uchida; Masao Kobayakawa; Naoki Asayama; Junichi Akiyama; Takuro Shimbo; Toru Igari; Rupa Banerjee; D Nageshwar Reddy; Masashi Mizokami; Naomi Uemura
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

8.  Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach.

Authors:  M M Weiss; E J Kuipers; C Postma; A M Snijders; M Stolte; M Vieth; D Pinkel; S G M Meuwissen; D Albertson; G A Meijer
Journal:  Mol Pathol       Date:  2003-10

Review 9.  Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.

Authors:  Lin Ding; Mohamad El Zaatari; Juanita L Merchant
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

10.  Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents.

Authors:  J M Thomas; J J Misiewicz; A R Cook; M J Hill; P L Smith; C L Walters; J K Forster; L E Martin; D F Woodings
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.